Vimarsana
Biggest News Aggregation in the World

Steven Pipe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Steven Pipe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Steven Pipe Today - Breaking & Trending Today

Gene Therapy for Hemophilia Becomes a Reality - Vimarsana News

Gene Therapy for Hemophilia Becomes a Reality

Uptake of new options for hemophilia A and B has been a bit slow

Sickle Cell Gene Therapy 'Truly Transformative' - Vimarsana News

Sickle Cell Gene Therapy 'Truly Transformative'

Patients who received lovo-cel had durable remissions and reductions in vaso-occlusive events, pain crises, and hospitalizations in the longest running gene therapy trial for sickle cell disease.

Emicizumab Safe, Effective, in Infants With Hemophilia A - Vimarsana News

Emicizumab Safe, Effective, in Infants With Hemophilia A

More than half of children in study had no treated bleeds at follow-up of more than 100 weeks

New Data Reinforce the Benefit of Early Preventative Treatment With Genentech's Hemlibra (emicizumab-kxwh) for Babies With Severe hemophilia A | National Business - Vimarsana News

New Data Reinforce the Benefit of Early Preventative Treatment With Genentech's Hemlibra (emicizumab-kxwh) for Babies With Severe hemophilia A | National Business

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Dec 9, 2023--

New Data Reinforce the Benefit of Early Preventative Treatment With Genentech's Hemlibra (emicizumab-kxwh) for Babies With Severe hemophilia A -December 09, 2023 at 11:31 am EST - Vimarsana News

New Data Reinforce the Benefit of Early Preventative Treatment With Genentech's Hemlibra (emicizumab-kxwh) for Babies With Severe hemophilia A -December 09, 2023 at 11:31 am EST

– Phase III HAVEN 7 primary data presented at ASH 2023 provide additional confidence in the favorable efficacy and safety profile of subcutaneous Hemlibra given soon after birth – – At nearly...